Soin Neuroscience
7076 Corporate Way
Dayton
Ohio
45458
United States
Website: http://www.soinneuroscience.com/
Email: drsoin@soinneuroscience.com
About Soin Neuroscience
Soin Neuroscience is a privately held, Ohio Based pharmaceutical company which is developing treatments for various chronic medical diseases using an oral formulation of sodium nitrite. Initial studies were done on patients with poor blood flow to the extremities, such as those suffering from peripheral artery disease (PAD). In the U.S., 16 – 19 million people suffer from PAD but no effective treatments are currently available. The Company’s first product is TV1001, and oral formulation of sodium nitrite to treat PAD.YEAR FOUNDED:
March 2017
LEADERSHIP:
Founder: Dr. Amol Soin
PIPELINE:
Please click here for Soin Neuroscienc's pipeline.
6 articles about Soin Neuroscience
-
Soin Neuroscience Tests Very Low Frequency Spinal Cord Stimulation in Humans
7/26/2023
Soin Neuroscience has announced that it has tested its TunedTX platform using very low frequency stimulation.
-
Soin Neuroscience Develops Novel Sacral Nerve Stimulator to Treat Bladder Incontinence
10/13/2020
Soin Neuroscience Inc. (SNI), a biotech startup based in Dayton, Ohio , has developed a novel implantable sacral nerve stimulator to treat bladder incontinence. As many as 46 million Americans 40 years of age or older have reported symptoms of urinary incontinence often due to a condition known as overactive bladder, according to th
-
Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Pain
1/22/2020
Soin Neuroscience, a biotechnology company based in Dayton, OH, has developed a new spinal cord stimulation device to treat chronic pain.
-
Soin Neuroscience commences a clinical case series with Nuvectra's Algovita spinal cord stimulator for back pain
3/8/2018
Soin Neuroscience has received IRB (institutional review board) approval to commence a clinical case series to study spinal cord stimulator algorithms in patients who suffer from back pain.
-
Soin Neuroscience Signs Drug Development Deal For Non Addicting Pain Killer
8/10/2017
-
Soin Neuroscience Files An Orphan Drug Application To Treat Systemic Sclerosis
6/7/2017